Best of ONS Congress Workshops

2019 Best of Congress Workshops

Looking for in-person oncology nursing education closer to home? Hear popular sessions from the ONS 44th Annual Congress and earn 7.25 continuing nursing education (CNE) contact hours while networking with 200 local oncology nurses. Discover techniques to improve patient outcomes and enhance the skills you need to provide optimal care to your patients. 

Taking place in three different cities, these workshops feature practical information in a convenient, one-day format. Click on the city nearest you to learn more and start making plans to attend. 

Register by August 29 to save $40 with early-bird pricing! 

Workshop Pricing:
Early-Bird: $99
Final (after August 29): $139

 

Cancellation Policy
If you wish to cancel your registration, you must notify ONS by sending your request via email to help@ons.org at least 30 days prior to the workshop date. ONS will provide you a monetary refund equal to the cost of the course registration minus a 30% cancellation fee.

No cancellations will be accepted after the 30-day cancellation window.

2019 Best of Congress Workshop (Minneapolis), September 13

Register Now

Friday, September 13 
7 am–5 pm


Crowne Plaza Aire
3 Appletree Square 
Bloomington, MN 55425


Schedule

7–7:45 am
Registration and Breakfast (Provided)

7:45–8 am
Welcome

8–10 am
Checks and Balances: Cancer Immunotherapy for the Advanced Practice Nurse
Krista Rubin MS, FNP-BC
Laura Wood, RN, MSN, OCN®

This two-hour session will provide an overview of immunotherapy for advanced practice nurses, focusing on currently approved agents, regimens, and modalities, as well as novel investigational agents currently in clinical trials. A case-based approach with an audience response tool will be used to engage participants in detailed interaction about immune-related adverse events, including presentation, assessment, intervention, and shared decision making.

10–10:15 am
Break

10:15–11:30 am
CAR-T: Where We Are and Where We are Going
Misty Lamprecht, MS, APRN-CNS, AOCN®, BMTCN®

CAR T-cell therapy is a new and upcoming treatment. During this session, a physician and advanced practice nurse will discuss the rationale for treatment and how patients are managed.

11:30–12:30 pm
Lunch (Provided)

12:30–1:45 pm
Hereditary Cancer Genetics 101: Providing Safe Care to Patients and Families
Suzanne Mahon, RN, DNSc, AOCN®, AGN-BC

In the past 20 years, major changes have occurred regarding genetic testing for hereditary risk. Learn how cancer risk assessment guides the identification of patients with potential genetic risk, genetic testing decisions, and recommendations for cancer prevention and early detection. This session also will describe how to manage patients with noninformative or unclear results.

1:45–2 pm
Break

2–3:15 pm
New Horizons: Immunotherapy and Radiation
Annette Quinn, MSN, RN, OCN®

Scientific evidence has emerged that shows radiotherapy can be very effective in creating immunogenic cell death, a form of cancer cell death that is effective at signaling the immune system. Radiation therapy also can send a series of “danger” signals that are sensed by the host’s immune system and can be harnessed to reject the tumor. Unfortunately, when radiotherapy is used alone, these effects generally are insufficient at causing tumor suppression. However, when combined with immunotherapy, such as immune checkpoint blockade, localized radiotherapy can effectively immunize the patient against the irradiated tumor, converting the tumor into an individualized vaccine. This session will explore radiation's role in the world of immunotherapy and how the abscopal effect comes into play in tumor eradication.

3:15–3:30 pm
Break

3:30–5 pm
Pharmacology Update
Teresa Knoop, MSN, RN, AOCN®

Are you familiar with the new cancer drugs that the U.S. Food and Drug Administration approved within the past year? Get introduced to these novel treatments while learning valuable tips to help you quickly identify drug classifications and use evidence-based interventions for managing treatments.

2019 Best of Congress Workshop (Phoenix), October 3

Register Now

Thursday, October 3 
7 am–5 pm


Sheraton Phoenix Airport Hotel Tempe
1600 S 52nd St. 
Tempe, AZ 85281


Schedule

7–7:45 am
Registration and Breakfast (Provided)

7:45–8 am
Welcome

8–10 am
Checks and Balances: Cancer Immunotherapy for the Advanced Practice Nurse
Krista Rubin MS, FNP-BC
Laura Wood, RN, MSN, OCN®

This two-hour session will provide an overview of immunotherapy for advanced practice nurses, focusing on currently approved agents, regimens, and modalities, as well as novel investigational agents currently in clinical trials. A case-based approach with an audience response tool will be used to engage participants in detailed interaction about immune-related adverse events, including presentation, assessment, intervention, and shared decision making.

10–10:15 am
Break

10:15–11:30 am
CAR-T: Where We Are and Where We are Going
Misty Lamprecht, MS, APRN-CNS, AOCN®, BMTCN®

CAR T-cell therapy is a new and upcoming treatment. During this session, a physician and advanced practice nurse will discuss the rationale for treatment and how patients are managed.

11:30–12:30 pm
Lunch (Provided)

12:30–1:45 pm
Hereditary Cancer Genetics 101: Providing Safe Care to Patients and Families
Suzanne Mahon, RN, DNSc, AOCN®, AGN-BC

In the past 20 years, major changes have occurred regarding genetic testing for hereditary risk. Learn how cancer risk assessment guides the identification of patients with potential genetic risk, genetic testing decisions, and recommendations for cancer prevention and early detection. This session also will describe how to manage patients with noninformative or unclear results.

1:45–2 pm
Break

2–3:15 pm
New Horizons: Immunotherapy and Radiation
Annette Quinn, MSN, RN, OCN®

Scientific evidence has emerged that shows radiotherapy can be very effective in creating immunogenic cell death, a form of cancer cell death that is effective at signaling the immune system. Radiation therapy also can send a series of “danger” signals that are sensed by the host’s immune system and can be harnessed to reject the tumor. Unfortunately, when radiotherapy is used alone, these effects generally are insufficient at causing tumor suppression. However, when combined with immunotherapy, such as immune checkpoint blockade, localized radiotherapy can effectively immunize the patient against the irradiated tumor, converting the tumor into an individualized vaccine. This session will explore radiation's role in the world of immunotherapy and how the abscopal effect comes into play in tumor eradication.

3:15–3:30 pm
Break

3:30–5 pm
Pharmacology Update
Teresa Knoop, MSN, RN, AOCN®

Are you familiar with the new cancer drugs that the U.S. Food and Drug Administration approved within the past year? Get introduced to these novel treatments while learning valuable tips to help you quickly identify drug classifications and use evidence-based interventions for managing treatments.

2019 Best of Congress Workshop (Philadelphia), October 17

Register Now

Thursday, October 17
7 am–5 pm


Crowne Plaza Philadelphia/Cherry Hill
2349 W. Marlton Pike
Cherry Hill, NJ 08002


Schedule

7–7:45 am
Registration and Breakfast (Provided)

7:45–8 am
Welcome

8–10 am
Checks and Balances: Cancer Immunotherapy for the Advanced Practice Nurse
Krista Rubin MS, FNP-BC
Laura Wood, RN, MSN, OCN®

This two-hour session will provide an overview of immunotherapy for advanced practice nurses, focusing on currently approved agents, regimens, and modalities, as well as novel investigational agents currently in clinical trials. A case-based approach with an audience response tool will be used to engage participants in detailed interaction about immune-related adverse events, including presentation, assessment, intervention, and shared decision making.

10–10:15 am
Break

10:15–11:30 am
CAR-T: Where We Are and Where We are Going
Misty Lamprecht, MS, APRN-CNS, AOCN®, BMTCN®

CAR T-cell therapy is a new and upcoming treatment. During this session, a physician and advanced practice nurse will discuss the rationale for treatment and how patients are managed.

11:30–12:30 pm
Lunch (Provided)

12:30–1:45 pm
Hereditary Cancer Genetics 101: Providing Safe Care to Patients and Families
Suzanne Mahon, RN, DNSc, AOCN®, AGN-BC

In the past 20 years, major changes have occurred regarding genetic testing for hereditary risk. Learn how cancer risk assessment guides the identification of patients with potential genetic risk, genetic testing decisions, and recommendations for cancer prevention and early detection. This session also will describe how to manage patients with noninformative or unclear results.

1:45–2 pm
Break

2–3:15 pm
New Horizons: Immunotherapy and Radiation
Annette Quinn, MSN, RN, OCN®

Scientific evidence has emerged that shows radiotherapy can be very effective in creating immunogenic cell death, a form of cancer cell death that is effective at signaling the immune system. Radiation therapy also can send a series of “danger” signals that are sensed by the host’s immune system and can be harnessed to reject the tumor. Unfortunately, when radiotherapy is used alone, these effects generally are insufficient at causing tumor suppression. However, when combined with immunotherapy, such as immune checkpoint blockade, localized radiotherapy can effectively immunize the patient against the irradiated tumor, converting the tumor into an individualized vaccine. This session will explore radiation's role in the world of immunotherapy and how the abscopal effect comes into play in tumor eradication.

3:15–3:30 pm
Break

3:30–5 pm
Pharmacology Update
Teresa Knoop, MSN, RN, AOCN®

Are you familiar with the new cancer drugs that the U.S. Food and Drug Administration approved within the past year? Get introduced to these novel treatments while learning valuable tips to help you quickly identify drug classifications and use evidence-based interventions for managing treatments.